Abstract:Abstract Aims/hypothesis The associations of sitting, standing, physical activity and sleep with cardiometabolic health and glycaemic control markers are interrelated. We aimed to identify 24 h time-use compositions associated with optimal metabolic and glycaemic control and determine whether these varied by diabetes status. Methods Thigh-worn activPAL data from 2388 participants aged 40–75 years (48.7% female; mean age 60.1 [SD = 8.1] years; n =684 with type 2 diabetes) in The Maastricht Study were examined. Compositional isometric log ratios were generated from mean 24 h time use (sitting, standing, light-intensity physical activity [LPA], moderate-to-vigorous physical activity [MVPA] and sleeping) and regressed with outcomes of waist circumference, fasting plasma glucose (FPG), 2 h plasma glucose, HbA 1c , the Matsuda index expressed as z scores, and with a clustered cardiometabolic risk score. Overall analyses were adjusted for demographics, smoking, dietary intake and diabetes status, and interaction by diabetes status was examined separately. The estimated difference when substituting 30 min of one behaviour with another was determined with isotemporal substitution. To identify optimal time use, all combinations of 24 h compositions possible within the study footprint (1st–99th percentile of each behaviour) were investigated to determine those cross-sectionally associated with the most-optimal outcome (top 5%) for each outcome measure. Results Compositions lower in sitting time and with greater standing time, physical activity and sleeping had the most beneficial associations with outcomes. Associations were stronger in participants with type 2 diabetes ( p <0.05 for interactions), with larger estimated benefits for waist circumference, FPG and HbA 1c when sitting was replaced by LPA or MVPA in those with type 2 diabetes vs the overall sample. The mean (range) optimal compositions of 24 h time use, considering all outcomes, were 6 h (range 5 h 40 min–7 h 10 min) for sitting, 5 h 10 min (4 h 10 min–6 h 10 min) for standing, 2 h 10 min (2 h–2 h 20 min) for LPA, 2 h 10 min (1 h 40 min–2 h 20 min) for MVPA and 8 h 20 min (7 h 30 min–9 h) for sleeping. Conclusions/interpretation Shorter sitting time and more time spent standing, undergoing physical activity and sleeping are associated with preferable cardiometabolic health. The substitutions of behavioural time use were significantly stronger in their associations with glycaemic control in those with type 2 diabetes compared with those with normoglycaemic metabolism, especially when sitting time was balanced with greater physical activity. Graphical Abstract

Associations between habitual sleep characteristics and cardiometabolic disease risk in corporate executives

0352 Association Between Sleep and Cardiovascular Disease Risk Factors in Sedentary Desk Workers

The association of cardiometabolic disorders with sleep duration: a cross-sectional study

Sleep patterns and risk of chronic disease as measured by long-term monitoring with commercial wearable devices in the All of Us Research Program

0017 Circadian Phase Alignment and Sleep Duration in Overweight Adults: Associations with Cardiometabolic Risk Factors

Device-Measured Weekend Catch-Up Sleep, Mortality, and Cardiovascular Disease Incidence in Adults

Joint Association of Sleep Onset Time and Sleep Duration with Cardiometabolic Health Outcome.

1109 The Impact of Sleep Duration and Its Variability on the Human Phenome: Analysis of All of Us Wearables Data

Sleep Extension in Short Sleepers: An Evaluation of Feasibility and Effectiveness for Weight Management and Cardiometabolic Disease Prevention

Sleep Irregularity and Subclinical Markers of Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis

Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study

0580 Sleep Attitudes as a Predictor of Risk for Metabolic Syndrome in College Freshman

Sleep Duration, Plasma Metabolites, and Obesity and Diabetes: a Metabolome-Wide Association Study in US Women.

The association between sleep duration and cardiometabolic risk among children and adolescents in the United States (US): A NHANES study

A Prospective Study of Sleep Duration and Coronary Heart Disease in Women

The Association Between Physical Activity, Sitting Time, Sleep Duration, and Sleep Quality as Correlates of Presenteeism

Association of sleep timing, sleep duration, and sleep latency with metabolic syndrome in middle-aged adults in Korea: A cross-sectional and longitudinal study

0131 Decreased Habitual Sleep Efficiency is Associated with Increased Insulin Resistance in Healthy Adult Men

The association of multidimensional sleep health with adiposity in heart failure with preserved ejection fraction

0876 Sleep and Body Mass Index: The Enduring Effects of Sleep Duration and Wake After Sleep Onset in College Students

Abstract P104: Change in Measures of Adiposity in Young Adulthood and Middle-Age Sleep Apnea Risk: The Bogalusa Heart Study